IL17A and depressive symptom measurement: A total of 180 signaling pathways (P < 0.05) were obtained by KEGG pathway enrichment screening, including the IL-17 signaling pathway, apoptosis, pathways of neurodegeneration-multiple diseases, dopaminergic synapse, cell cycle, long-term depression, and neuroactive ligand-receptor interaction.